FIRE1

FIRE1 is a medical device company based in Dublin, Ireland, founded in 2013. It focuses on improving heart failure management through innovative remote monitoring technology. The company’s flagship product, the NORM system, is an investigational implantable heart failure monitor. This system allows patients to manage their condition at home with a simple implant, a wearable belt for daily use, and a smartphone app for tracking heart status. This continuous monitoring provides valuable data for both patients and healthcare providers, enabling timely treatment adjustments. FIRE1 aims to empower heart failure patients to regain normal lives through effective self-management and early intervention. The company has secured significant funding, including a $120 million round led by Polaris Partners and Elevage Medical Technologies, with participation from notable investors like Medtronic and Novo Holdings. FIRE1 is committed to regulatory excellence, having received Breakthrough Device Designation from the FDA and is working towards FDA approval by 2029. Its mission is to address critical needs in cardiac care and enhance patient independence and quality of life.

• Employees 65
• Founded 2014
• Annual Revenue $3400000
• Total Funding $202137214